{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:17:04Z","timestamp":1791897424236,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["NET-2018-12365454"],"award-info":[{"award-number":["NET-2018-12365454"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to assess the long-term outcome of patients with acromegaly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This is a multicenter, retrospective, observational study which extends the mean observation period of a previously reported cohort of Italian patients with acromegaly to 15\u00a0years of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Only patients from the centers that provided information on the life status of at least 95% of their original cohorts were included. Life status information was collected either from clinical records or from the municipal registry offices. Standardized mortality ratios (SMRs) were computed comparing data with those of the general Italian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 811 patients were included. There were 153 deaths, with 90 expected and an SMR of 1.7 (95% CI 1.4\u20132.0,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Death occurred after a median of 15 (women) or 16 (men) years from the diagnosis, without gender differences. Mortality remained elevated in the patients with control of disease (SMR 1.3, 95% CI 1.1\u20131.6). In the multivariable analysis, only older age and high IGF1 concentrations at last available follow-up visit were predictors of mortality. The oncological causes of death outweighed the cardiovascular ones, bordering on statistical significance with respect to the general population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mortality remains significantly high in patients with acromegaly, irrespectively of disease status, as long as the follow-up is sufficiently long with a low rate of patients lost to follow-up. Therapy strategy including radiotherapy does not have an impact on mortality. Oncological causes of death currently outweigh the cardiovascular causes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-023-02257-3","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T10:02:48Z","timestamp":1705053768000},"page":"1457-1465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy"],"prefix":"10.1007","volume":"47","author":[{"given":"M.","family":"Arosio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sciannameo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-8516","authenticated-orcid":false,"given":"A.","family":"Contarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Berchialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Pesatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Filopanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Rochira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"De Menis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pigliaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Grottoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Cambria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Faustini-Fustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Peri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Puxeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Borretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bondanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ferone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Terzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Reimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"issue":"11","key":"2257_CR1","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1172\/JCI39375","volume":"119","author":"S Melmed","year":"2009","unstructured":"Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Investig 119(11):3189\u20133202. https:\/\/doi.org\/10.1172\/JCI39375","journal-title":"J Clin Investig"},{"key":"2257_CR2","doi-asserted-by":"publisher","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","DOI":"10.1210\/jc.2014-2700"},{"issue":"1","key":"2257_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","volume":"20","author":"A Lavrentaki","year":"2017","unstructured":"Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N (2017) Epidemiology of acromegaly: review of population studies. Pituitary 20(1):4\u20139. https:\/\/doi.org\/10.1007\/s11102-016-0754-x","journal-title":"Pituitary"},{"issue":"1","key":"2257_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","volume":"40","author":"MR Gadelha","year":"2019","unstructured":"Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40(1):268\u2013332. https:\/\/doi.org\/10.1210\/er.2018-00115","journal-title":"Endocr Rev"},{"issue":"153","key":"2257_CR5","first-page":"1","volume":"39","author":"AD Wright","year":"1970","unstructured":"Wright AD, Hill DM, Lowy C, Fraser TR (1970) Mortality in acromegaly. Q J Med 39(153):1\u201316","journal-title":"Q J Med"},{"issue":"1","key":"2257_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93(1):61\u201367. https:\/\/doi.org\/10.1210\/jc.2007-1191","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2257_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/EJE-08-0267","volume":"159","author":"IM Holdaway","year":"2008","unstructured":"Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159(2):89\u201395. https:\/\/doi.org\/10.1530\/EJE-08-0267","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2257_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1210\/er.2009-0033","volume":"31","author":"M Sherlock","year":"2010","unstructured":"Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM (2010) Mortality in patients with pituitary disease. Endocr Rev 31(3):301\u2013342. https:\/\/doi.org\/10.1210\/er.2009-0033","journal-title":"Endocr Rev"},{"issue":"7","key":"2257_CR9","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1210\/jc.2004-1381","volume":"90","author":"R Kauppinen-M\u00e4kelin","year":"2005","unstructured":"Kauppinen-M\u00e4kelin R, Sane T, Reunanen A, V\u00e4lim\u00e4ki MJ, Niskanen L, Markkanen H, L\u00f6yttyniemi E, Ebeling T, Jaatinen P, Laine H, Nuutila P, Salmela P, Salmi J, Stenman UH, Viikari J, Voutilainen E (2005) A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab 90(7):4081\u20134086. https:\/\/doi.org\/10.1210\/jc.2004-1381","journal-title":"J Clin Endocrinol Metab"},{"key":"2257_CR10","doi-asserted-by":"publisher","unstructured":"Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannav\u00f2 S, Minuto F, Montini M, Bondanelli M, De Menis E, Martini C, Angeletti G, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Appetecchia M, Cavagnini F, Lombardi G, Ghigo E, Beck-Peccoz P, Colao A, Terzolo M, Italian Study Group of Acromegaly (2012) Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol 167(2):189\u201398. https:\/\/doi.org\/10.1530\/EJE-12-0084","DOI":"10.1530\/EJE-12-0084"},{"issue":"3","key":"2257_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/EJE-13-0166","volume":"169","author":"F Bogazzi","year":"2013","unstructured":"Bogazzi F, Colao A, Rossi G, Lombardi M, Urbani C, Sardella C, Iannelli A, Scattina I, Manetti L, Del Sarto S, Pivonello R, Grasso LF, Lupi I, Auriemma RS, Lombardi G, Martino E (2013) Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Eur J Endocrinol 169(3):367\u2013376. https:\/\/doi.org\/10.1530\/EJE-13-0166","journal-title":"Eur J Endocrinol"},{"key":"2257_CR12","doi-asserted-by":"publisher","unstructured":"Mercado M, Gonzalez B, Vargas G, Ramirez C, de los Monteros AL, Sosa E, Jervis P, Roldan P, Mendoza V, L\u00f3pez-F\u00e9lix B, Guinto G (2014) Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab 99(12):4438\u20134446. https:\/\/doi.org\/10.1210\/jc.2014-2670","DOI":"10.1210\/jc.2014-2670"},{"key":"2257_CR13","doi-asserted-by":"publisher","unstructured":"Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F, Chabre O, Fran\u00e7ois P, Bertherat J, Cortet-Rudelli C, Chanson P, French Acromegaly Registry Group (2017) Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur J Endocrinol 176(5):645\u2013655. https:\/\/doi.org\/10.1530\/EJE-16-1064","DOI":"10.1530\/EJE-16-1064"},{"issue":"1","key":"2257_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12020-022-03275-6","volume":"80","author":"CM Falch","year":"2023","unstructured":"Falch CM, Olarescu NC, Bollerslev J, Dekkers OM, Heck A (2023) Trends in incidence and mortality risk for acromegaly in Norway: a cohort study. Endocrine 80(1):152\u2013159. https:\/\/doi.org\/10.1007\/s12020-022-03275-6","journal-title":"Endocrine"},{"issue":"3","key":"2257_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1530\/EJE-21-0729","volume":"186","author":"S Arnard\u00f3ttir","year":"2022","unstructured":"Arnard\u00f3ttir S, J\u00e4r\u00e5s J, Burman P, Berinder K, Dahlqvist P, Erfurth EM, H\u00f6ybye C, Larsson K, Ragnarsson O, Ekman B, Ed\u00e9n EB (2022) Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register. Eur J Endocrinol 186(3):329\u2013339. https:\/\/doi.org\/10.1530\/EJE-21-0729","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2257_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/EJE-18-0255","volume":"179","author":"F Bolfi","year":"2018","unstructured":"Bolfi F, Neves AF, Boguszewski CL, Nunes-Nogueira VS (2018) Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur J Endocrinol 179(1):59\u201371. https:\/\/doi.org\/10.1530\/EJE-18-0255","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2257_CR17","doi-asserted-by":"publisher","first-page":"L5","DOI":"10.1530\/EJE-19-0509","volume":"181","author":"F Bolfi","year":"2019","unstructured":"Bolfi F, Neves AF, Boguszewski CL, Nunes-Nogueira VS (2019) Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur J Endocrinol 181(5):L5\u2013L6. https:\/\/doi.org\/10.1530\/EJE-19-0509","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2257_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.02.001","volume":"33","author":"L Maione","year":"2019","unstructured":"Maione L, Chanson P (2019) National acromegaly registries. Best Pract Res Clin Endocrinol Metab 33(2):101264. https:\/\/doi.org\/10.1016\/j.beem.2019.02.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2257_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/ERC-16-0106","volume":"23","author":"E Ritvonen","year":"2016","unstructured":"Ritvonen E, L\u00f6yttyniemi E, Jaatinen P, Ebeling T, Moilanen L, Nuutila P, Kauppinen-M\u00e4kelin R, Schalin-J\u00e4ntti C (2016) Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer 23(6):469\u2013480. https:\/\/doi.org\/10.1530\/ERC-16-0106","journal-title":"Endocr Relat Cancer"},{"key":"2257_CR20","doi-asserted-by":"publisher","unstructured":"Terzolo M, Reimondo G, Berchialla P, Ferrante E, Malchiodi E, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S, Ferone D, Montini M, Bondanelli M, De Menis E, Martini C, Puxeddu E, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Peraga G, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Berton A, Serban AL, Baldelli R, Fatti LM, Colao A, Arosio M, Italian Study Group of Acromegaly (2017) Acromegaly is associated with increased cancer risk: a survey in Italy. Endocr Relat Cancer 24(9):495\u2013504. https:\/\/doi.org\/10.1530\/ERC-16-0553","DOI":"10.1530\/ERC-16-0553"},{"issue":"11","key":"2257_CR21","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(11):3888\u20133921. https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2257_CR22","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE (2020) 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension 75(6):1334\u20131357. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15026","journal-title":"Hypertension"},{"key":"2257_CR23","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee (2022) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142022. Diabetes Care 45(Suppl 1):S17\u2013S38. https:\/\/doi.org\/10.2337\/dc22-S002.","DOI":"10.2337\/dc22-S002"},{"issue":"5","key":"2257_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1530\/EJE-13-0924","volume":"170","author":"B Delemer","year":"2014","unstructured":"Delemer B, Chanson P, Foubert L, Borson-Chazot F, Chabre O, Tabarin A, Weryha G, Cortet-Rudelli C, Raingeard I, Reznik Y, Reines C, Bisot-Locard S, Castinetti F (2014) Patients lost to follow-up in acromegaly: results of the ACROSPECT study. Eur J Endocrinol 170(5):791\u2013797. https:\/\/doi.org\/10.1530\/EJE-13-0924","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2257_CR25","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/EJE-19-1023","volume":"182","author":"NF Lenders","year":"2020","unstructured":"Lenders NF, McCormack AI, Ho KKY (2020) Management of endocrine disease: does gender matter in the management of acromegaly? Eur J Endocrinol 182(5):R67\u2013R82. https:\/\/doi.org\/10.1530\/EJE-19-1023","journal-title":"Eur J Endocrinol"},{"key":"2257_CR26","doi-asserted-by":"publisher","unstructured":"Park KH, Lee EJ, Seo GH, Ku CR (2020) Risk for acromegaly-related comorbidities by sex in Korean acromegaly. J Clin Endocrinol Metab 105(4):dgz317. https:\/\/doi.org\/10.1210\/clinem\/dgz317","DOI":"10.1210\/clinem\/dgz317"},{"key":"2257_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/cen.14392","volume":"94","author":"J Dal","year":"2021","unstructured":"Dal J, Skov BG, Andersen M, Feldt-Rasmussen U, Feltoft CL, Karmisholt J, Nielsen EH, Dekkers OM, J\u00f8rgensen JO (2021) Sex differences in acromegaly at diagnosis: a nationwide cohort study and meta-analysis of the literature. Clin Endocrinol (Oxford) 94:625\u2013635. https:\/\/doi.org\/10.1111\/cen.14392","journal-title":"Clin Endocrinol (Oxford)"},{"issue":"11\u201312","key":"2257_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1159\/000505332","volume":"110","author":"JC Wu","year":"2020","unstructured":"Wu JC, Huang WC, Chang HK, Ko CC, Lirng JF, Chen YC (2020) Natural history of acromegaly: incidences, re-operations, cancers, and mortality rates in a national cohort. Neuroendocrinology 110(11\u201312):977\u2013987. https:\/\/doi.org\/10.1159\/000505332","journal-title":"Neuroendocrinology"},{"key":"2257_CR29","doi-asserted-by":"publisher","unstructured":"Mustacchi P, Shimkin MB (1857) Occurrence of cancer in acromegaly and in hypopituitarism. Cancer 10(1):100\u20134. https:\/\/doi.org\/10.1002\/1097-0142(195701\/02)10:1<100::aid-cncr2820100113>3.0.co;2-v","DOI":"10.1002\/1097-0142(195701\/02)10:1<100::aid-cncr2820100113>3.0.co;2-v"},{"issue":"1","key":"2257_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11154-007-9063-z","volume":"9","author":"S Loeper","year":"2008","unstructured":"Loeper S, Ezzat S (2008) Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord 9(1):41\u201358. https:\/\/doi.org\/10.1007\/s11154-007-9063-z","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"2257_CR31","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1530\/EJE-16-0178","volume":"175","author":"CL Boguszewski","year":"2016","unstructured":"Boguszewski CL, Ayuk J (2016) Management of endocrine disease: acromegaly and cancer: an old debate revisited. Eur J Endocrinol 175(4):R147\u2013R156. https:\/\/doi.org\/10.1530\/EJE-16-0178","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2257_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1023\/a:1015713732717","volume":"13","author":"D Baris","year":"2002","unstructured":"Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni JF Jr (2002) Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13(5):395\u2013400. https:\/\/doi.org\/10.1023\/a:1015713732717","journal-title":"Cancer Causes Control"},{"issue":"12","key":"2257_CR33","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1210\/clinem\/dgab560","volume":"106","author":"D Esposito","year":"2021","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2021) Incidence of benign and malignant tumors in patients with acromegaly is increased: a nationwide population-based study. J Clin Endocrinol Metab 106(12):3487\u20133496. https:\/\/doi.org\/10.1210\/clinem\/dgab560","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2257_CR34","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1210\/jc.2017-02457","volume":"103","author":"J Dal","year":"2018","unstructured":"Dal J, Leisner MZ, Hermansen K, Farkas DK, Bengtsen M, Kistorp C, Nielsen EH, Andersen M, Feldt-Rasmussen U, Dekkers OM, S\u00f8rensen HT, J\u00f8rgensen JOL (2018) Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature. J Clin Endocrinol Metab 103(6):2182\u20132188. https:\/\/doi.org\/10.1210\/jc.2017-02457","journal-title":"J Clin Endocrinol Metab"},{"key":"2257_CR35","doi-asserted-by":"publisher","unstructured":"Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83(8):2730\u20134. https:\/\/doi.org\/10.1210\/jcem.83.8.5007","DOI":"10.1210\/jcem.83.8.5007"},{"issue":"10","key":"2257_CR36","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1210\/jc.2015-2372","volume":"100","author":"D Petroff","year":"2015","unstructured":"Petroff D, T\u00f6njes A, Grussendorf M, Droste M, Dimopoulou C, Stalla G, Jaursch-Hancke C, Mai M, Schopohl J, Sch\u00f6fl C (2015) The incidence of cancer among acromegaly patients: results from the German Acromegaly Registry. J Clin Endocrinol Metab 100(10):3894\u20133902. https:\/\/doi.org\/10.1210\/jc.2015-2372","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2257_CR37","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41574-022-00702-6","volume":"18","author":"JJ Kopchick","year":"2022","unstructured":"Kopchick JJ, Basu R, Berryman DE, Jorgensen JOL, Johannsson G, Puri V (2022) Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer. Nat Rev Endocrinol 18(9):558\u2013573. https:\/\/doi.org\/10.1038\/s41574-022-00702-6","journal-title":"Nat Rev Endocrinol"},{"key":"2257_CR38","doi-asserted-by":"publisher","unstructured":"Vila G, Luger A, van der Lely AJ, Neggers SJCMM, Webb SM, Biller BMK, Valluri S, Hey-Hadavi J (2020) Hypertension in acromegaly in relationship to biochemical control and mortality: global ACROSTUDY outcomes. Front Endocrinol (Lausanne) 11:577173. https:\/\/doi.org\/10.3389\/fendo.2020.577173","DOI":"10.3389\/fendo.2020.577173"},{"issue":"9","key":"2257_CR39","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1210\/clinem\/dgac400","volume":"107","author":"D Esposito","year":"2022","unstructured":"Esposito D, Olsson DS, Franz\u00e9n S, Miftaraj M, N\u00e5tman J, Gudbj\u00f6rnsdottir S, Johannsson G (2022) Effect of diabetes on morbidity and mortality in patients with acromegaly. J Clin Endocrinol Metab 107(9):2483\u20132492. https:\/\/doi.org\/10.1210\/clinem\/dgac400","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2257_CR40","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1530\/EJE-20-1124","volume":"184","author":"OM Dekkers","year":"2021","unstructured":"Dekkers OM, Groenwold RHH (2021) When observational studies can give wrong answers: the potential of immortal time bias. Eur J Endocrinol 184(1):E1\u2013E4. https:\/\/doi.org\/10.1530\/EJE-20-1124","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"2257_CR41","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/eurheartj\/ehab822","volume":"43","author":"S Hong","year":"2022","unstructured":"Hong S, Kim KS, Han K, Park CY (2022) Acromegaly and cardiovascular outcomes: a cohort study. Eur Heart J 43(15):1491\u20131499. https:\/\/doi.org\/10.1093\/eurheartj\/ehab822","journal-title":"Eur Heart J"},{"issue":"1","key":"2257_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000375163","volume":"103","author":"J McCabe","year":"2016","unstructured":"McCabe J, Ayuk J, Sherlock M (2016) Treatment factors that influence mortality in acromegaly. Neuroendocrinology 103(1):66\u201374. https:\/\/doi.org\/10.1159\/000375163","journal-title":"Neuroendocrinology"},{"issue":"3","key":"2257_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/EJE-16-0117","volume":"175","author":"J Dal","year":"2016","unstructured":"Dal J, Feldt-Rasmussen U, Andersen M, Kristensen L\u00d8, Laurberg P, Pedersen L, Dekkers OM, S\u00f8rensen HT, J\u00f8rgensen JO (2016) Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175(3):181\u2013190. https:\/\/doi.org\/10.1530\/EJE-16-0117","journal-title":"Eur J Endocrinol"},{"key":"2257_CR44","doi-asserted-by":"publisher","unstructured":"Knappe UJ, Petroff D, Quinkler M, Schmid SM, Sch\u00f6fl C, Schopohl J, Stieg MR, T\u00f6njes A, Participants of the German Acromegaly Registry (2020) Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry. Eur J Endocrinol 182(3):275\u2013284. https:\/\/doi.org\/10.1530\/EJE-19-0784","DOI":"10.1530\/EJE-19-0784"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02257-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02257-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02257-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T12:26:03Z","timestamp":1717158363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02257-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02257-3","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study, named \u201cACROLIFE,\u201d was approved by the Institutional Ethic Committee of the Fondazione IRCCS Ca\u2019 Granda Policlinico Hospital, Milan 2, with authorization number 2749 on 11\/27\/2020. This study was conducted according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study (<i>n<\/i> = 811).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}